Caspase Recruitment Domain-Containing Protein 9 Expression is a Novel Prognostic Factor for Lung Adenocarcinoma
Open Access
- 1 September 2020
- journal article
- research article
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 13, 9005-9013
Abstract
Purpose: Caspase recruitment domain-containing protein 9 (CARD9) is expressed at high levels in bone marrow cells and has a crucial role in innate immunity. Current studies indicate that CARD9 also plays a key role in tumor progression, but there are few reports on the role of CARD9 in lung cancer. The aim of this study was to clarify the role of CARD9 in lung adenocarcinoma. Patients and Methods: Lung adenocarcinoma tumor samples from 74 patients who underwent complete resection at Kobe University Hospital from January 2014 to December 2014 were analyzed by immunohistochemistry. The role of CARD9 in cancer cells was analyzed using lung cancer cell lines treated with CARD9 siRNA. Results: High expression of CARD9 was observed in 32.4% of tumors, and compared to low expression of CARD9, high expression was associated with poorer overall survival (P = 0.0365). Univariate and multivariate analyses showed that high expression of CARD9 was an independent prognostic factor. Knockdown of CARD9 in lung adenocarcinoma cells inhibited proliferation but did not increase apoptosis. In addition, CARD9 activated the NF-κB pathway in a lung adenocarcinoma cell line. Conclusion: CARD9 was shown to be an independent prognostic factor of poor outcome for lung cancer and may represent a molecular target for treatment.Keywords
This publication has 27 references indexed in Scilit:
- Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillanceThe Journal of Thoracic and Cardiovascular Surgery, 2013
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- NF-κB, the first quarter-century: remarkable progress and outstanding questionsGenes & Development, 2012
- Structure-Function Relationship of Cytoplasmic and Nuclear IκB Proteins: An In Silico AnalysisPLOS ONE, 2010
- Non-canonical NF-κB signaling pathwayCell Research, 2010
- A single NFκB system for both canonical and non-canonical signalingCell Research, 2010
- Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient dataThe Lancet, 2010
- CARD9 Signaling in the Innate Immune ResponseAnnals of the New York Academy of Sciences, 2008
- NFκB pathway: A good signaling paradigm and therapeutic targetThe International Journal of Biochemistry & Cell Biology, 2006
- How NF-κB is activated: the role of the IκB kinase (IKK) complexOncogene, 1999